Filing Details

Accession Number:
0001209191-19-059734
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-09 17:10:47
Reporting Period:
2019-12-05
Accepted Time:
2019-12-09 17:10:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1373707 Tetraphase Pharmaceuticals Inc TTPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296998 Guy Macdonald 480 Arsenal St. Suite 110
Watertown MA 02472
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-05 1,870 $2.34 5,985 No 4 S Direct
Common Stock Disposition 2019-12-06 5,735 $2.25 250 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The number of shares of common stock reported on this Form 4 reflects a 1-for -20 reverse stock split effected on September 26, 2019.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $2.34 to $2.35 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission,the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $2.25 to $2.29 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission,the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.